Genmab

-$0.22 (-0.50%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genmab and other ETFs, options, and stocks.

About GMAB

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases.

CEO
Jan G. J. van de Winkel
Employees
781
Headquarters
Copenhagen, Capital Region
Founded
1999

GMAB Key Statistics

Market Cap
29.02B
Price-Earnings Ratio
71.63
Dividend Yield
—
Average Volume
450.92K
High Today
$44.56
Low Today
$43.93
Open Price
$44.27
Volume
225.86K
52 Week High
$49.07
52 Week Low
$30.10

GMAB Earnings

$0.00
$2.53
$5.05
$7.58
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 3
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure